Select Page
FDA Tentative Approval: Vasopressin Injectable Therapy

FDA Tentative Approval: Vasopressin Injectable Therapy

The U.S. Food and Drug Administration (FDA) has granted a tentative approval for Amphastar’s Abbreviated New Drug Application (ANDA) for an injectable vasopressin therapy to increase blood pressure in adults with vasodilatory shock. As part of the clinical syndrome of...